Not all clinical trials study cancer treatments. Clinical trials also study ways to improve quality of life and reduce side effects, as well as collect information to advance cancer research. These types of trials are called non-treatment, non-therapeutic, non-interventional, or observational studies. We recently introduced the importance of non-treatment clinical trials. Here we continue our series on different types of non-treatment trials.
When faced with cancer or a change in how your cancer is responding to treatment, you may have decisions to make with your doctor about what to do next. This month, we are highlighting trials that study ways to guide treatment decisions and predict response to treatment. Visit the links below to learn more and find trials on Metastatic Trial Search studying new ways to make decisions about treatment and predict treatment response.
Predicting Response to Treatment
- American Association for Cancer Research: Biomarker to Predict Response to Immunotherapy
- Fred Hutchinson Cancer Center: Machine Learning to Identify Biomarkers that Predict Response to Immunotherapy
- OncLive: Predicting Response to Chemotherapy in MBC
Decision Support
- ASCO (Article and Video): Making Decisions About Cancer Treatment
- Memorial Sloan Kettering: CT Scans and MRI to Select Cancer Treatment
- National Cancer Institute: Biomarker Testing to Select Cancer Treatment
- Young Survival Coalition (Video): Biomarker Testing and MBC
- Metastatic Breast Cancer Alliance: Genetic and Biomarker Testing
- Facing Hereditary Cancer Empowered (FORCE): Genetic Testing
MBC Clinical Trials
- Metastatic Trial Search: Trials for Treatment Decision Support
- Metastatic Trial Search: Trials for Predicting Response to Treatment